Integre Asset Management adds AmerisourceBergen Corp. (ABC) to its portfolio

AmerisourceBergen Corp. (ABC) : Integre Asset Management added new position in AmerisourceBergen Corp. during the most recent quarter end. The investment management firm now holds 82,763 shares of AmerisourceBergen Corp. which is valued at $7,358,458 , the company said in a statement filed on Aug 15, 2016 with the SEC.AmerisourceBergen Corp. makes up approximately 2.40% of Integre Asset Management’s portfolio.

Other Hedge Funds, Including , Aqr Capital Management reduced its stake in ABC by selling 1,213,973 shares or 36.54% in the most recent quarter. The Hedge Fund company now holds 2,108,229 shares of ABC which is valued at $187,442,640. AmerisourceBergen Corp. makes up approx 0.32% of Aqr Capital Management’s portfolio.Symphony Asset Management reduced its stake in ABC by selling 34 shares or 1.04% in the most recent quarter. The Hedge Fund company now holds 3,238 shares of ABC which is valued at $287,891. AmerisourceBergen Corp. makes up approx 0.05% of Symphony Asset Management’s portfolio.Ajo Lp reduced its stake in ABC by selling 212,026 shares or 91.94% in the most recent quarter. The Hedge Fund company now holds 18,580 shares of ABC which is valued at $1,647,489. AmerisourceBergen Corp. makes up approx 0.01% of Ajo Lp’s portfolio.Glenmede Trust Co Na reduced its stake in ABC by selling 188,483 shares or 84.53% in the most recent quarter. The Hedge Fund company now holds 34,491 shares of ABC which is valued at $3,081,771. AmerisourceBergen Corp. makes up approx 0.02% of Glenmede Trust Co Na’s portfolio.

AmerisourceBergen Corp. opened for trading at $87.6 and hit $88.439 on the upside on Wednesday, eventually ending the session at $87.75, with a gain of 0.14% or 0.12 points. The heightened volatility saw the trading volume jump to 1,513,718 shares. Company has a market cap of $18,843 M.

On the company’s financial health, AmerisourceBergen Corp. reported $1.37 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.27. The company had revenue of $36900.00 million for the quarter, compared to analysts expectations of $36705.18 million. The company’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.20 EPS.

Many Wall Street Analysts have commented on AmerisourceBergen Corp.. Company shares were Reiterated by Mizuho on Aug 11, 2016 to “Neutral”, Firm has raised the Price Target to $ 90 from a previous price target of $80 .Company shares were Reiterated by FBR Capital on Aug 3, 2016 to “Mkt Perform”, Firm has raised the Price Target to $ 90 from a previous price target of $84 .Company shares were Reiterated by Barclays on Aug 3, 2016 to “Equal Weight”, Firm has raised the Price Target to $ 89 from a previous price target of $83 .

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally the Company offers healthcare providers and pharmaceutical manufacturers with services including reimbursement and pharmaceutical consulting services logistics services inventory management pharmacy automation and pharmacy management. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States.

Leave a Reply

AmerisourceBergen Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on AmerisourceBergen Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.